1. Home
  2. SAIC vs KYMR Comparison

SAIC vs KYMR Comparison

Compare SAIC & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAIC
  • KYMR
  • Stock Information
  • Founded
  • SAIC 1969
  • KYMR 2015
  • Country
  • SAIC United States
  • KYMR United States
  • Employees
  • SAIC N/A
  • KYMR N/A
  • Industry
  • SAIC EDP Services
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • SAIC Technology
  • KYMR Health Care
  • Exchange
  • SAIC Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • SAIC 4.8B
  • KYMR 4.2B
  • IPO Year
  • SAIC N/A
  • KYMR 2020
  • Fundamental
  • Price
  • SAIC $101.39
  • KYMR $56.83
  • Analyst Decision
  • SAIC Hold
  • KYMR Strong Buy
  • Analyst Count
  • SAIC 9
  • KYMR 17
  • Target Price
  • SAIC $121.89
  • KYMR $61.65
  • AVG Volume (30 Days)
  • SAIC 520.1K
  • KYMR 910.5K
  • Earning Date
  • SAIC 09-04-2025
  • KYMR 10-30-2025
  • Dividend Yield
  • SAIC 1.46%
  • KYMR N/A
  • EPS Growth
  • SAIC 49.05
  • KYMR N/A
  • EPS
  • SAIC 8.26
  • KYMR N/A
  • Revenue
  • SAIC $7,460,000,000.00
  • KYMR $44,711,000.00
  • Revenue This Year
  • SAIC $0.15
  • KYMR $62.11
  • Revenue Next Year
  • SAIC $1.03
  • KYMR N/A
  • P/E Ratio
  • SAIC $12.26
  • KYMR N/A
  • Revenue Growth
  • SAIC 2.23
  • KYMR N/A
  • 52 Week Low
  • SAIC $94.68
  • KYMR $19.45
  • 52 Week High
  • SAIC $156.34
  • KYMR $59.00
  • Technical
  • Relative Strength Index (RSI)
  • SAIC 42.81
  • KYMR 65.68
  • Support Level
  • SAIC $95.30
  • KYMR $54.09
  • Resistance Level
  • SAIC $101.31
  • KYMR $59.00
  • Average True Range (ATR)
  • SAIC 2.55
  • KYMR 2.39
  • MACD
  • SAIC 0.66
  • KYMR 0.30
  • Stochastic Oscillator
  • SAIC 67.76
  • KYMR 80.00

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: